Pharmacyclics (PCYC) Tops Q1 EPS by 32c, Revenue Misses
Tweet
Share
E-mailGet Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Loss from operations: 3.78M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Loss from operations: 3.78M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Pharmacyclics (NASDAQ: PCYC) reported Q1 EPS of $0.43, $0.32 better than the analyst estimate of $0.11. Revenue for the quarter came in at $206 million versus the consensus estimate of $226.27 million.
For earnings history and earnings-related data on Pharmacyclics (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
